Cargando…

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole

Detalles Bibliográficos
Autores principales:	Kotorki, Paraskevi, Pelka, Parthena, Leotsakou, Christina, Kalogeropoulou, Aikaterini, Fiste, Markella, Vagionis, Georgios, Roussi, Anastasia, Paterakis, Periklis
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991852/ http://dx.doi.org/10.1186/1744-859X-9-S1-S164

Ejemplares similares

Treatment of bipolar mania with paliperidone extended-release
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Guillain-Barre syndrome and mood disorders
por: Neroutsos, Evangelos, et al.
Publicado: (2010)

Anticonvulsant treatment and mood disorders. A Vitamine B12 key role?
por: Neroutsos, Evangelos, et al.
Publicado: (2010)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Aripiprazole-induced Hyperprolactinemia in a Young Female with Delusional Disorder
por: Joseph, Sam Padamadan
Publicado: (2016)

Fugue and aphonia as first and foremost presentations of a case of psychosis
por: Leotsakou, Christina, et al.
Publicado: (2010)

Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
por: Rosenbloom, Arlan L.
Publicado: (2010)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
por: Kelly, Deanna L, et al.
Publicado: (2013)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

Correction: Hyperprolactinemia with antipsychotic drugs in children and adolescents
por: Rosenbloom, Arlan L
Publicado: (2013)

Hyperprolactinemia with antipsychotics and the need for magnetic resonance imaging
por: Molina Liétor, M.D.C., et al.
Publicado: (2022)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
por: Montejo, A.L., et al.
Publicado: (2022)

Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Ling, et al.
Publicado: (2021)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
por: Kohen, Izchak, et al.
Publicado: (2010)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
por: Zhao, Jingyuan, et al.
Publicado: (2015)

Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process
por: Kim, Hye Ri, et al.
Publicado: (2023)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto, Kojiro, et al.
Publicado: (2014)

Successful treatment of a prolactinoma with the antipsychotic drug aripiprazole
por: Bakker, Ilse C A, et al.
Publicado: (2016)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency
por: Hsu, Rai-Hseng, et al.
Publicado: (2023)

TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel
por: Veznedaroglu, Baybars, et al.
Publicado: (2018)

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
por: Ivanova, Svetlana, et al.
Publicado: (2016)

Aripiprazole for olanzapine-induced symptomatic hyper prolactinemia
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Hyperprolactinemia in patients taking antipsychotics: the importance of a shared approach between psychiatry and endocrinology
por: Mousinho, M., et al.
Publicado: (2023)

Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis
por: Lu, Zhe, et al.
Publicado: (2022)

Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
por: Wang, Zhongbao, et al.
Publicado: (2023)

Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)

New Cocrystals of Antipsychotic Drug Aripiprazole: Decreasing the Dissolution through Cocrystallization
por: Liu, Wenwen, et al.
Publicado: (2021)

Antipsychotic Drug Aripiprazole Protects Liver Cells from Oxidative Stress
por: Kramar, Barbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t5gcec9c8q24v71m3pnm8lrsv4